top of page

The Neurovascular Unit in Stroke: A Target for Therapeutic Intervention

  • Mar 26, 2025
  • 2 min read


Introduction:

Stroke is a leading cause of death and disability worldwide, primarily affecting the brain’s blood supply and neuronal function. Traditionally, stroke treatment has focused on restoring blood flow and reducing neuronal damage. However, recent research has identified the neurovascular unit (NVU) as a crucial component in stroke pathology and recovery. The NVU consists of neurons, endothelial cells, astrocytes, pericytes, and microglia, all working together to maintain cerebrovascular health and brain function. Targeting the NVU in stroke therapy offers new opportunities for improving outcomes and reducing long-term damage.


The Role of the Neurovascular Unit in Stroke:

The NVU plays a vital role in blood-brain barrier (BBB) integrity, cerebral blood flow regulation, and neuroinflammation. Stroke disrupts these functions, leading to severe brain injury.

1. Blood-Brain Barrier (BBB) Dysfunction:

  • The BBB is a selective barrier that protects the brain from harmful substances while allowing essential nutrients to pass through.

  • During a stroke, BBB integrity is compromised due to inflammatory cytokines and oxidative stress, leading to vascular leakage, edema, and secondary brain damage.

  • Therapeutic approaches targeting tight junction proteins (claudin, occludin) may help restore BBB function and reduce damage.

2. Endothelial Cell Damage and Blood Flow Dysregulation:

  • Endothelial cells lining blood vessels in the NVU control cerebral blood flow.

  • In ischemic stroke, endothelial dysfunction leads to reduced oxygen and nutrient delivery, exacerbating neuronal injury.

  • Treatments such as vascular endothelial growth factor (VEGF) inhibitors and angiogenesis-promoting therapies aim to restore endothelial function and improve blood circulation.

3. Astrocytes and Neuroinflammation:

  • Astrocytes, star-shaped glial cells, play a key role in maintaining NVU homeostasis and supporting neuronal function.

  • Following a stroke, astrocytes become reactive, releasing inflammatory mediators that contribute to brain injury.

  • Therapies targeting astrocyte-mediated inflammation, such as anti-inflammatory drugs and neuroprotective agents, may help improve stroke recovery.

4. Microglia and Immune Response:

  • Microglia, the brain’s resident immune cells, respond rapidly to stroke-induced injury.

  • While microglia initially help clear debris, prolonged activation leads to neuroinflammation and secondary neuronal death.

  • Therapeutic interventions focusing on microglial modulation using minocycline and other immunomodulatory drugs may help balance the inflammatory response.

Therapeutic Strategies Targeting the Neurovascular Unit:

  • Neuroprotective drugs: Agents like N-acetylcysteine (NAC) and edaravone help reduce oxidative stress and inflammation.

  • Stem cell therapy: Promotes NVU repair by replacing damaged neurons and supporting vascular regeneration.

  • Nanotechnology-based drug delivery: Enhances targeted therapy, improving drug penetration across the BBB.


Conclusion:

The neurovascular unit is an essential target for stroke therapy, as it regulates vascular integrity, blood flow, and neuroinflammation. By focusing on NVU components such as endothelial cells, astrocytes, and microglia, novel therapeutic strategies can limit brain damage and promote functional recovery. Future research into NVU-targeted therapies, regenerative medicine, and drug delivery technologies holds great promise for improving stroke outcomes and reducing disability.


The domain www.dubaitelemedicine.com is for sale. Please contact us at www.kneetie.com

 
 
 

Comments

About Dr. Viveck Baluja and KneeTie Vascular Neurology

Dr. Viveck Baluja, MD, is a board-certified vascular neurologist (American Board of Psychiatry and Neurology — Vascular Neurology) practicing telemedicine across California, Michigan, and Colorado, with additional consultation services available to international families, particularly in India.

KneeTie offers three focused services: emergency stroke second opinions delivered within 24 hours, traumatic brain injury (TBI) consultations for survivors and caregivers, and same-day adult ADHD evaluations for residents of CA, MI, and CO.

Stroke Second Opinion

After a stroke, families often have minutes to make decisions. Dr. Baluja provides a second set of expert eyes from a board-certified vascular neurologist — reviewing imaging, hospital records, and current treatment — typically within 24 hours of request. Common questions include: Was tPA appropriate? Should we pursue thrombectomy? What is the recovery outlook? What rehabilitation makes sense?

TBI Consultation

Traumatic brain injury recovery is rarely linear. Dr. Baluja helps patients and families understand recovery timelines, treatment options, post-concussion syndrome, and red flags that warrant emergency evaluation. Consultations typically last 50 minutes and are scheduled within the same week.

Same-Day Adult ADHD Evaluation

A real evaluation by a board-certified neurologist — not a 7-minute screening. Dr. Baluja's ADHD evaluations include comprehensive history, sleep and lifestyle assessment, and behavioral strategy alongside any medication discussion. Available same-day for residents of California, Michigan, and Colorado.

Why a Vascular Neurologist?

Vascular neurology is a subspecialty focused on stroke, cerebrovascular disease, and brain blood flow — among the rarest neurology subspecialties in the U.S. Most online telehealth services use general practitioners or nurse practitioners. KneeTie is led by a board-certified vascular neurologist with full state licensure and HIPAA-compliant telehealth infrastructure.

Schedule a consultation: Use the booking calendar above to choose a service and reserve a time. For active stroke or post-tPA emergencies, email gorungo@kneetie.com directly with "URGENT" in the subject line.

© 2020 KneeTie, Jagannatha Health LLC 

bottom of page